Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Cancer|June 1, 1983
Neuromyopathy of cyanide intoxication due to "laetrile" (amygdalin). A clinicopathologic studyU P Kalyanaraman, K Kalyanaraman, S A Cullinan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanomaR F Morton, E T Creagan, S A Cullinan, et al.Medical and Pediatric Oncology|January 1, 1988
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinomaR F Marschke, L K Kvols, S A Cullinan, et al.Cancer Treatment Reports|August 1, 1986
Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatmentJ H Edmonson, J E Krook, J F Hilton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment GroupS A Cullinan, C G Moertel, H S Wieand, et al.American Journal of Clinical Oncology|April 1, 1988
Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinomaJ H Edmonson, P S Johnson, H S Wieand, et al.Breast Cancer Research and Treatment|March 1, 1989
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerJ C Buckner, J N Ingle, L K Everson, et al.JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.Cancer Treatment Reports|November 1, 1985
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomasJ H Edmonson, G W McCormack, T R Fleming, et al.Pageof 2